Literature DB >> 19158087

Source of phosphate in the enzymic reaction as a point of distinction among aminoglycoside 2''-phosphotransferases.

Marta Toth1, Joseph W Chow, Shahriar Mobashery, Sergei B Vakulenko.   

Abstract

Aminoglycoside 2''-phosphotransferases are clinically important enzymes that cause high levels of resistance to aminoglycoside antibiotics by the organisms that harbor them. These enzymes phosphorylate aminoglycosides, and the modified antibiotics show significant reduction in the binding ability to target the bacterial ribosome. This report presents a detailed characterization of the antibiotic resistance profile and the aminoglycoside and nucleotide triphosphate substrate profiles of four common aminoglycoside 2''-phosphotransferases widely distributed in clinically important Gram-positive microorganisms. Although the antibiotic resistance phenotypes exhibited by these enzymes are similar, their aminoglycoside and nucleotide triphosphate substrate profiles are distinctive. Contrary to the dogma that these enzymes use ATP as the source of phosphate in their reactions, two of the four aminoglycoside 2'-phosphotransferases utilize GTP as the phosphate donor. Of the other two enzymes, one exhibits preference for ATP, and the other can utilize either ATP or GTP as nucleotide triphosphate substrate. A new nomenclature for these enzymes is put forth that takes into account the differences among these enzymes based on their respective substrate preferences. These nucleotide triphosphate preferences should have ramifications for understanding of the evolution, selection, and dissemination of the genes for these important resistance enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158087      PMCID: PMC2652286          DOI: 10.1074/jbc.M808148200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Aminoglycoside antibiotics. Structures, functions, and resistance.

Authors:  G D Wright; A M Berghuis; S Mobashery
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

Review 2.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

3.  Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms.

Authors:  S A Waksman; H A Lechevalier
Journal:  Science       Date:  1949-03-25       Impact factor: 47.728

4.  Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium.

Authors:  J W Chow; V Kak; I You; S J Kao; J Petrin; D B Clewell; S A Lerner; G H Miller; K J Shaw
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

5.  Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study.

Authors:  Bernd Heinzl; Ernst Eber; Béatrice Oberwaldner; Gertrude Haas; Maximilian S Zach
Journal:  Pediatr Pulmonol       Date:  2002-01

6.  Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site.

Authors:  Beatriz Llano-Sotelo; Eduardo F Azucena; Lakshmi P Kotra; Shahriar Mobashery; Christine S Chow
Journal:  Chem Biol       Date:  2002-04

7.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

Review 8.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  Fluorinated aminoglycosides and their mechanistic implication for aminoglycoside 3'-phosphotransferases from Gram-negative bacteria.

Authors:  Choonkeun Kim; Jalal Haddad; Sergei B Vakulenko; Samy O Meroueh; Yan Wu; Honggao Yan; Shahriar Mobashery
Journal:  Biochemistry       Date:  2004-03-09       Impact factor: 3.162

10.  Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria.

Authors:  R Benveniste; J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

View more
  24 in total

1.  Aminoglycoside 2''-phosphotransferase IIIa (APH(2'')-IIIa) prefers GTP over ATP: structural templates for nucleotide recognition in the bacterial aminoglycoside-2'' kinases.

Authors:  Clyde A Smith; Marta Toth; Hilary Frase; Laura J Byrnes; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

2.  Structural basis for dual nucleotide selectivity of aminoglycoside 2''-phosphotransferase IVa provides insight on determinants of nucleotide specificity of aminoglycoside kinases.

Authors:  Kun Shi; Albert M Berghuis
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

3.  Structure and function of APH(4)-Ia, a hygromycin B resistance enzyme.

Authors:  Peter J Stogios; Tushar Shakya; Elena Evdokimova; Alexei Savchenko; Gerard D Wright
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

4.  Bulky "gatekeeper" residue changes the cosubstrate specificity of aminoglycoside 2''-phosphotransferase IIa.

Authors:  Monolekha Bhattacharya; Marta Toth; Clyde A Smith; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

5.  Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.

Authors:  Peter J Stogios; Peter Spanogiannopoulos; Elena Evdokimova; Olga Egorova; Tushar Shakya; Nick Todorovic; Alfredo Capretta; Gerard D Wright; Alexei Savchenko
Journal:  Biochem J       Date:  2013-09-01       Impact factor: 3.857

6.  Purification, crystallization and preliminary X-ray analysis of Enterococcus casseliflavus aminoglycoside-2''-phosphotransferase-IVa.

Authors:  Marta Toth; Sergei Vakulenko; Clyde A Smith
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-12-25

7.  Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.

Authors:  Marta Toth; Hilary Frase; Joseph W Chow; Clyde Smith; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

8.  Structure of the bifunctional aminoglycoside-resistance enzyme AAC(6')-Ie-APH(2'')-Ia revealed by crystallographic and small-angle X-ray scattering analysis.

Authors:  Clyde A Smith; Marta Toth; Thomas M Weiss; Hilary Frase; Sergei B Vakulenko
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-09-27

9.  The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.

Authors:  Wenlong Cai; Anwesha Goswami; Zhaoyong Yang; Xiaodong Liu; Keith D Green; Sandra Barnard-Britson; Satoshi Baba; Masanori Funabashi; Koichi Nonaka; Manjula Sunkara; Andrew J Morris; Anatol P Spork; Christian Ducho; Sylvie Garneau-Tsodikova; Jon S Thorson; Steven G Van Lanen
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

10.  Structure of the antibiotic resistance factor spectinomycin phosphotransferase from Legionella pneumophila.

Authors:  Desiree H Fong; Christopher T Lemke; Jiyoung Hwang; Bing Xiong; Albert M Berghuis
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.